FeNO study in ICU patients with breathing support
Part of Lungs & breathing clinical trials.
This study measures a lung inflammation marker called FeNO in ICU patients on a breathing machine. It may help doctors understand lung health and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the ICU and need a breathing machine or advanced breathing support
- Your breathing tube is expected to stay in for more than 24 hours
- You agree to take part and sign a consent form
- You haven't taken certain medicines (like nitroglycerin or anti-inflammatory drugs) in the past 6 hours, and you aren't in another research study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device that measures a lung marker called FeNO (fractional exhaled nitric oxide) to help diagnose asthma. It may be an option for adults with asthma who have not changed their medication recently and have no recent infections.
This study tests whether inhaled nitric oxide (a gas you breathe in) can improve oxygen delivery to your lungs in patients with severe acute respiratory distress syndrome (ARDS) who are using non-invasive breathing support instead of a breathing tube. The goal is to help your lungs deliver oxygen more efficiently to your blood.
This trial is testing whether a simple breath test (FeNO) can predict how well immunotherapy works in people with advanced lung cancer who haven't had treatment before. It's for patients whose tumors have high PD-L1 levels and who will receive immunotherapy alone.
This trial is testing whether a simple breath test called FeNO can help doctors diagnose asthma more accurately. It's for people who have symptoms that might be asthma, but haven't been diagnosed yet.
This study tests an inhaled gas (iNO300) given through your breathing tube to improve oxygen levels in critically ill patients with pneumonia. You may qualify if you are on a ventilator and have been diagnosed with pneumonia within the last 3 days.
This trial tests a handheld device that measures nitric oxide in your breath to see if it can help monitor asthma. You may qualify if you have uncontrolled asthma and can use the device at home.
Hear when a new Compare the Concentration of Exhaled Nitric Oxide in Patients With Different Severity of RF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.